Pharmaceuticals, Biotechnology and Life Sciences
The Milken Institute COVID-19 Treatment and Vaccine Tracker has identified more than 111 vaccines and 197 treatments in the pipeline to treat and prevent COVID-19.
During the COVID-19 crisis, it is critical for companies in the pharmaceutical market to take calculative and well-executed measures to ensure business continuity in the long run.
Arcturus Therapeutics and Catalent have entered a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to protect against the SARS-CoV-2 coronavirus.
Truxima, the only US biosimilar to Rituxan, is also now available for the treatment of Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA).
Adare Pharmaceuticals has bought a technology company Orbis Biosciences, aiming to enhance its own Pharmaceutical Technologies business, creating products for global pharma, animal health and OTC markets.
Kala Pharmaceuticals has resubmitted its New Drug Application to the FDA for Eysuvis, its product candidate to treat dry eye disease.
PALO ALTO, Calif.–(BUSINESS WIRE)–#biotech—Medable, Inc., the leading global platform for decentralized clinical trials, today announced $25 million in funding to…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP) today announced the appointment of Dr. Geoff Cotton, MB BS, MBA to its Board of…
LOS ANGELES–(BUSINESS WIRE)–Myst Therapeutics (Myst), a preclinical stage biotechnology company focused on developing selected TIL-based autologous T cell (PuriT™) therapy…
− Highly Potent and Broadly Cross-Reactive RNAi Therapeutic Development Candidate Selected Only Three Months After Program Initiation − − Companies…